According to a new market report published by Lucintel, the future of the molecular cytogenetic market looks promising with opportunities in applications, such as genetic disorders, cancer, and personalized medicine. The global molecular cytogenetic market is expected to grow with a CAGR of 10% from 2020 to 2025. The major drivers for this market are increasing incidence of genetic disorders & cancer and growing focus on targeted cancer treatment.
To download report brochure, please go to https://www.lucintel.com/molecular-cytogenetic-market.aspx and click "download brochure" tab from the menu
Molecular cytogenetics is a large set of the techniques that operate either with the entire genome or with specific targeted DNA sequences. In this market, kits and reagents, instruments, consumables, and software & services are the major product segments. Lucintel forecasts that kits and reagents will remain the largest product segment over the forecast period due to the increasing incidence of genetic disorders and cancer.
Within this market, clinical and research laboratories will remain the largest end user segment over the forecast period due to the growing implementation of cytogenetic techniques in clinical diagnosis.
North America will remain the largest region over the forecast period due to the local presence of major entities, such as Agilent Technologies and Abbott Laboratories. Moreover, the presence of an effective regulatory framework for the regulation of genetic tests in the region acts as a growth booster for the North American molecular cytogenetic market.
Roche, Danaher, Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Illumina are among the major suppliers in the global molecular cytogenetic market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global molecular cytogenetic market by product, technique, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Molecular Cytogenetic Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global molecular cytogenetic market by product, technique, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Testing Kits
Probes
Fluorescent Affinity Reagents
Other Kits & Reagents
Instruments
Consumables
Software & Services
By Technique [Value ($ Million) shipment analysis for 2014 – 2025]:
Comparative Genomic Hybridization
Array-Based Comparative Genomic Hybridization
Standard Comparative Genomic Hybridization
Fluorescence in Situ Hybridization
In Situ Hybridization
Other Techniques
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Genetic Disorders
Cancer
Personalized Medicine
Other Applications
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Clinical & Research Laboratories
Academic Research Institutes
Pharmaceutical and Biotechnology Companies
Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
Spain
Italy
France
This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.